HR 6454 establishes a 5-year pilot program at five Department of Veterans Affairs (VA) medical centers to improve suicide care for veterans. The program requires VA staff at these sites to complete a 10-week training curriculum based on the Zero Suicide Institute's model, focusing on suicide screening, risk assessment, safety planning, and care transitions. It mandates annual reports to Congress tracking staff training completion, policy alignment with the Institute's standards, and comparisons of suicide-related outcomes (like screenings and hospitalizations) between pilot sites and other VA facilities. The pilot includes one site primarily serving rural veterans and requires site selection based on factors like regional suicide rates and staff capacity. The program will conclude after five years unless the VA extends it for up to two more years.
VetPAC Act of 2025 This bill establishes the Veterans Health Administration Policy Advisory Commission for purposes of reviewing operations at the Veterans Health Administration and preparing reports with recommendations for Congress based on such review.
This bill requires the Department of Veterans Affairs (VA) to create a new project team within 180 days to overhaul how veterans schedule health care appointments. The team must develop a centralized system showing all available appointments across VA facilities and providers, a self-service online platform for veterans to book appointments (including referrals), and a phone-based scheduling option for veterans to book appointments directly. These changes must be completed within one year of the bill's enactment, with progress reports to Congress on costs, challenges, and metrics. The bill directly affects veterans seeking VA health care by aiming to make scheduling more efficient and accessible across all VA services.
HR 4611 (EACH Act of 2025) requires all federally funded health programs - including Medicaid, Medicare, military health plans, and the Indian Health Service - to cover abortion services without restrictions, repealing the Hyde Amendment's long-standing ban on federal funding for most abortions. This directly affects millions of people enrolled in these programs, particularly low-income women, women of color (including 25% of Black women and 22% of Hispanic women on Medicaid), and young people. The bill mandates coverage in all federally administered health plans and prohibits state or private insurers from restricting abortion coverage in health insurance. It aims to eliminate current federal and state barriers that deny abortion access to people who rely on government health programs.
This bill requires the VA to provide telehealth services, mail-order pharmacy benefits, and mandatory beneficiary travel payments to veterans residing in the Freely Associated States (including Palau, the Marshall Islands, and Micronesia) within one year of enactment. It mandates quarterly reporting to Congress on implementation progress and associated costs. The law directly affects veterans in these Pacific Island nations by expanding access to critical healthcare and travel support services previously not uniformly guaranteed.
HR 6595 requires the Secretaries of Defense and Veterans Affairs to create action plans at military medical facilities and VA hospitals to improve veteran access to care. These plans must include cross-credentialing providers, sharing resources at facilities with excess capacity, improving communication between agencies, and establishing secure complaint processes for veterans. The bill mandates annual congressional briefings on progress, costs, patient volumes, and safety incidents, with a deadline of September 30, 2028. It directly affects enrolled veterans seeking care at DOD facilities identified as having available capacity.
Aviation Funding Solvency Act This bill provides continuing appropriations to the Federal Aviation Administration (FAA) if (1) an appropriations bill for the FAA has not been enacted before a fiscal year begins, or (2) a law making continuing appropriations for the FAA is not in effect. Specifically, the bill provides appropriations from the Aviation Insurance Revolving Fund at the rate of operations that was provided for the prior fiscal year to continue programs, projects, and activities that were funded in the preceding fiscal year. The FAA may use the balance of the fund, minus $1 billion. If the FAA determines that the amounts from the fund are insufficient to continue all programs, projects, or activities, then the FAA must prioritize compensation payments for employees of the Air Traffic Organization (e.g., air traffic controllers). The bill provides the appropriations until the date on which either (1) specified appropriations legislation for the fiscal year becomes law, or (2) a bill making continuing appropriations becomes law. Finally, the bill permanently extends the FAA Non-premium War Risk Insurance Program. This program provides aviation insurance without a premium to eligible air carriers at the request of the Department of Defense or another federal agency, provided that the agency agrees to indemnify the FAA from all losses covered under the insurance. Eligible air carriers include those whose operations are under a federal contract and are necessary for national security or to carry out U.S. foreign policy.
The Reliable Power Act requires the Electric Reliability Organization (ERO) to conduct annual assessments of the U.S. power grid's ability to maintain reliable electricity supply, including analyzing generation resources, transmission needs, and risks of shortages during extreme weather. If the ERO identifies a risk of insufficient generation, it notifies the Federal Energy Regulatory Commission (FERC), which then alerts federal agencies like the Environmental Protection Agency (EPA) and Department of Energy (DOE) developing regulations affecting power generation. These agencies must submit proposed regulations for FERC review before finalizing them, and FERC can recommend changes to prevent reliability risks, with agencies required to respond to FERC’s comments. The bill directly affects federal agencies creating energy-related rules and aims to prevent power shortages by integrating grid reliability into the rulemaking process.
HCONRES 64 is a congressional resolution directing the President to withdraw U.S. military forces from any hostilities against Venezuela that lack explicit congressional authorization. It applies to ongoing military operations in Venezuela not approved by Congress through a declaration of war or specific law authorizing force. The resolution invokes the War Powers Resolution (50 U.S.C. 1544(c)), requiring the removal of troops within the timeframe specified by that law. This bill does not affect military actions already authorized by Congress but mandates the end of unapproved operations.
This Senate resolution recognizes community care - treatment outside VA facilities - as essential for meeting veterans' health needs. It affirms that community care complements, rather than replaces, VA health services, as established by the 2018 VA MISSION Act. The resolution urges the VA to fully implement the MISSION Act to ensure veterans receive timely care through community providers when VA facilities cannot meet their needs. It does not create new programs or funding but formally supports existing community care access as a key part of veteran healthcare.
This bill reclassifies pharmacy benefit managers (PBMs) as fiduciaries under federal law, requiring them to act in the best interest of group health plans they serve. It mandates PBMs to disclose all compensation sources (including rebates and fees) and prohibits them from shielding themselves from liability for breaches of duty. The law directly affects PBMs, employers offering health plans, and health insurers that use PBM services. Key provisions include new transparency rules, clarifying that PBMs cannot be the "responsible fiduciary" for disclosure purposes, and banning contracts that exempt PBMs from accountability.
FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
